Search Results - "Kiberd, B."

Refine Results
  1. 1
  2. 2

    Cancer Mortality in Kidney Transplantation by Kiberd, B. A., Rose, C., Gill, J. S.

    Published in American journal of transplantation (01-08-2009)
    “…Immunosuppression is associated with an increased risk of cancer in kidney transplant recipients compared to the general population. It is less clear whether…”
    Get full text
    Journal Article
  3. 3

    Estimated Impact of Deemed Consent Legislation for Organ Donation on Individuals With Kidney Failure: A Dynamic Decision Analytic Model by P., Koto, J., Vinson A., A., Kiberd B., S., Beed, K., Krmpotic, J., Dirk, J., Weiss M., Tennankore, Karthik K.

    “…Background: There is little data modeling the impact of deemed consent legislation (eligible individuals who do not register their decision to decline to be a…”
    Get full text
    Journal Article
  4. 4

    Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later? by Kiberd, B. A., Doucette, K., Vinson, A. J., Tennankore, K. K.

    Published in American journal of transplantation (01-10-2018)
    “…Currently many but not all centers transplant hepatitis C virus (HCV) viremic positive (+) donor kidneys into HCV+ recipients. Directed donation of HCV+ organs…”
    Get full text
    Journal Article
  5. 5

    Donor-Recipient Matching in Kidney Transplant: We're Not There Yet by Vinson, A.J., Tennankore, K.K., Kiberd, B.A.

    Published in Transplantation proceedings (01-07-2021)
    “…Strategic organ allocation is expected to prolong patient and graft survival after transplant. This study explored differences in graft survival when kidneys…”
    Get full text
    Journal Article
  6. 6

    Screening to Prevent Polyoma Virus Nephropathy in Kidney Transplantation: A Cost Analysis by Smith, F., Panek, R., Kiberd, B. A.

    Published in American journal of transplantation (01-09-2009)
    “…Polyoma virus nephropathy is an important cause of graft dysfunction in kidney transplant recipients and screening to prevent disease has been advocated…”
    Get full text
    Journal Article
  7. 7

    De Novo Donor‐Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis by Kiberd, B. A., Miller, A., Martin, S., Tennankore, K. K.

    Published in American journal of transplantation (01-11-2016)
    “…Screening for de novo donor‐specific antibodies (dnDSA) in stable kidney transplant recipients is routine practice in some centers. Patients with DSA are at…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling by Clase, C. M., Mahalati, K., Kiberd, B. A., Lawen, J. G., West, K. A., Fraser, A. D., Belitsky, P.

    Published in American journal of transplantation (01-09-2002)
    “…This study used receiver operating characteristic analysis to investigate the properties of area under the concentration‐time curve during the first 4 h after…”
    Get full text
    Journal Article
  12. 12

    Access to the Kidney Transplant Wait List by Kiberd, B., Boudreault, J., Bhan, V., Panek, R.

    Published in American journal of transplantation (01-11-2006)
    “…The study examines selection for kidney transplantation and determines who are referred, how many had contraindications and whether comorbidity indices predict…”
    Get full text
    Journal Article
  13. 13

    Approaching the therapeutic window for cyclosporine in kidney transplantation : A prospective study by MAHALATI, Kamran, BELITSKY, Philip, WEST, Kenneth, KIBERD, Bryce, FRASER, Albert, SKETRIS, Ingrid, MACDONALD, Alan S, MCALISTER, Vivian, LAWEN, Joseph

    “…Neoral dosing is traditionally based on cyclosporine (CyA) trough levels (C(0)). Four-h area under the curve (AUC(0-4)) for Neoral in the early…”
    Get full text
    Journal Article
  14. 14

    Treatment of Hypercholesterolemia With Ezetimibe in the Kidney Transplant Population by Puthenparumpil, J.J., Keough-Ryan, T., Kiberd, M., Lawen, J., Kiberd, B.A.

    Published in Transplantation proceedings (01-03-2005)
    “…Given the high incidence of lipid abnormalities, high burden of cardiovascular disease, and high proportion who do not achieve target levels despite therapy in…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    BK virus nephropathy in a heart transplant recipient: case report and review of the literature by Barber, C.E.H., Hewlett, T.J.C., Geldenhuys, L., Kiberd, B.A., Acott, P.D., Hatchette, T.F.

    Published in Transplant infectious disease (01-06-2006)
    “…: The human polyomavirus BK virus (BKV) remains latent in the urinary tract and may be reactivated in immunocompromised states. BKV is noted to be the…”
    Get full text
    Journal Article
  16. 16

    Discriminative Ability of Dye Injected Into a Meat Model to Determine Accuracy of Ultrasound-Guided Injection by Brownbridge, Regan G, Kiberd, Mathew B, Werry, Daniel, Bailey, Jonathan G

    “…The utility of using meat models for ultrasound-guided regional anesthesia simulation training has been well established. Feedback is considered the most…”
    Get full text
    Journal Article
  17. 17

    MDR1 C3435T Polymorphisms Correlate With Cyclosporine Levels in De Novo Renal Recipients by Foote, C.J., Greer, W., Kiberd, B.A., Fraser, A., Lawen, J., Nashan, B., Belitsky, P.

    Published in Transplantation proceedings (01-11-2006)
    “…Single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene correlate with the intestinal function of P-glycoprotein (PGP). PGP serves as a…”
    Get full text
    Journal Article
  18. 18

    Polyoma virus-induced hemorrhagic cystitis in renal transplantation patient with polyoma virus nephropathy by Singh, D., Kiberd, B., Gupta, R., Alkhudair, W., Lawen, J.

    Published in Urology (Ridgewood, N.J.) (01-02-2006)
    “…We report a biopsy proven case of hemorrhagic cystitis in a cadaveric renal transplant patient with hematuria. Because more and more polyoma virus infection is…”
    Get full text
    Journal Article
  19. 19

    Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency by Tonelli, Marcello, Bohm, Clara, Pandeya, Sanjaya, Gill, John, Levin, Adeera, Kiberd, Bryce A.

    Published in American journal of kidney diseases (01-03-2001)
    “…Cardiovascular Disease (CVD) is a major cause of morbidity and mortality among patients with chronic renal insufficiency (CRI). β-Adrenergic blockers,…”
    Get full text
    Journal Article
  20. 20